U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
CLAZAKIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
ALD-518
Preferred Name English
ALD518
Code English
Clazakizumab [WHO-DD]
Common Name English
CLAZAKIZUMAB (Aglycosylated IGG1 humanized rabbit antibody directed against IL6)
Common Name English
clazakizumab [INN]
Common Name English
CLAZAKIZUMAB [USAN]
Common Name English
RECOMBINANT HUMANIZED CHIMERIC HUMAN-LEPORINE IgG1 KAPPA ANTI-INTERLEUKIN 6 MONOCLONAL ANTIBODY
Common Name English
BMS-945429
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 612317
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
Code System Code Type Description
CAS
1236278-28-6
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
INN
9599
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
USAN
YY-119
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
DRUG BANK
DB12849
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
SMS_ID
100000142906
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
NCI_THESAURUS
C82359
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
EVMPD
SUB117542
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
WIKIPEDIA
BMS-945429
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
FDA UNII
4S38Z8RA9O
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108589
Created by admin on Mon Mar 31 21:25:37 GMT 2025 , Edited by admin on Mon Mar 31 21:25:37 GMT 2025
PRIMARY
ACTIVE MOIETY
CLAZAKIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966